drugset / Trial / NCT07367958

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects

NCT07367958 ↗

Phase 1 Completed 218 enrolled Celltrion
RandomizedParallel-groupOpen-labelOther

Summary

This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogenicity of the Auto-injector and Pre-filled syringe of CT-P52 in Healthy Male Subjects.

Timeline

Start
2026-01-26
Primary completion
2026-07-01
Completion
2026-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject CT-P52 Unknown 80 mg Subcutaneous

Indications

No indication recorded.